Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members: https://mms.businesswire.com/media/20221001005004/en/1589832/5/AEP_Quote_-_George_Renaudin.jpg
ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members


Humana Inc. (NYSE: HUM) today released details of its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2023 – with a clear focus on benefits and support based on what its

Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis: https://mms.businesswire.com/media/20220929005711/en/1587282/5/DHR-Powder_6b-Flow-Samples_Overall.jpg
Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis


Waters Corporation (NYSE:WAT) today introduced new, innovative powder rheology tooling and software for its TA Instruments™ HR Rheometers allowing scientists to make preciseii, repeatable powder

Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility: https://mms.businesswire.com/media/20220926005707/en/1582828/5/DJI_0884_%281%29.jpg
Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility


Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, today announced its newly built Precision Chemical Manufacturing Facility in Taunton, Mass. has achieved LEED

Humana Finalizes Launch of CenterWell Home Health
Humana Finalizes Launch of CenterWell Home Health


Humana Inc. (NYSE: HUM) has announced the completion of its initiative to rebrand the home health division of Kindred at Home (KAH) as CenterWell Home Health. With today’s announcement, CenterWell

CenterWell Senior Primary Care to Open 9 Senior-Focused Care Centers in and Around Phoenix
CenterWell Senior Primary Care to Open 9 Senior-Focused Care Centers in and Around Phoenix


CenterWell Senior Primary Care will open nine new senior-focused primary care centers in the Phoenix area through early 2023, marking the company’s debut in the Arizona market, giving local seniors

DGAP-Adhoc: Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
DGAP-Adhoc: Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius
DGAP-Adhoc: Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
DGAP-Adhoc: Fresenius SE & Co. KGaA: Significantly worsening headwinds at Fresenius Medical Care impact Group net income in FY/22; Fresenius SE & Co. KGaA Group guidance revised : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
DGAP-Adhoc: Fresenius SE & Co. KGaA: Significantly worsening headwinds at Fresenius Medical Care impact Group net income in FY/22; Fresenius SE & Co. KGaA Group guidance revised
DGAP-Adhoc: Fresenius SE & Co. KGaA: Significantly worsening headwinds at Fresenius Medical Care impact Group net income in FY/22; Fresenius SE & Co. KGaA Group guidance revised
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA cuts outlook for FY 2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA cuts outlook for FY 2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA cuts outlook for FY 2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets
Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish
Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish


Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of the Dexcom G6 mobile app in Spanish

Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins
Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins


Waters Corporation (NYSE:WAT) announced it is providing both technology and expertise to help advance plant-based protein science in collaboration with researchers of the Plant Protein Innovation

Humana Foundation Announces Scholarship Awards
Humana Foundation Announces Scholarship Awards


The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, announced 75 winners of college scholarships awarded through The Humana Foundation Scholarship

Humana Launches CenterWell Pharmacy and CenterWell Specialty Pharmacy
Humana Launches CenterWell Pharmacy and CenterWell Specialty Pharmacy


Humana Inc. (NYSE: HUM), a leading health and well-being company, has announced that Humana Pharmacy and Humana Specialty Pharmacy are now CenterWell Pharmacy and CenterWell Specialty Pharmacy

Waters stellt hochauflösende Massenspektrometrie-Produkte und -Software zur Beschleunigung der Wirkstoffentwicklung vor
Waters stellt hochauflösende Massenspektrometrie-Produkte und -Software zur Beschleunigung der Wirkstoffentwicklung vor


ASMS 2022 – Die Waters Corporation (NYSE:WAT) hat heute auf der Jahreskonferenz der American Society for Mass Spectrometry 2022 (ASMS) neue Instrumente, Softwarelösungen und Produktverbesserungen

Waters Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development
Waters Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development


ASMS 2022 – Waters Corporation (NYSE:WAT) today unveiled new instruments, software and product enhancements to drive drug discovery and development at the American Society for Mass Spectrometry

Humana Adds 14 States in Phase 2 of CenterWell Home Health Launch
Humana Adds 14 States in Phase 2 of CenterWell Home Health Launch


Humana Inc. (NYSE: HUM) has announced the addition of 14 states to the ongoing initiative to rebrand the home health division of Kindred at Home (KAH) as CenterWell Home Health. The announcement of

Prince Edward Island Becomes a National Leader in Providing Coverage for Dexcom G6 Continuous Glucose Monitoring System for Canadians With Diabetes
Prince Edward Island Becomes a National Leader in Providing Coverage for Dexcom G6 Continuous Glucose Monitoring System for Canadians With Diabetes


Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), announced today that people with type 1 and type 2 diabetes age two and over on multiple daily

DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22
Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab
Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab


Waters Corporation (NYSE: WAT) and The University of Delaware announced the grand opening of Immerse™ Delaware, a new Waters innovation and research laboratory. As part of their multi-year research

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care
DGAP-News: Carl Zeiss Meditec acquires two manufacturers of surgical instrumentshttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Carl Zeiss Meditec acquires two manufacturers of surgical instruments
DGAP-News: Carl Zeiss Meditec acquires two manufacturers of surgical instruments
Waters stellt Xevo TQ Absolute vor – das empfindlichste und kompakteste Tandem-Quadrupol-Massenspektrometer für den Tischeinsatz
Waters stellt Xevo TQ Absolute vor – das empfindlichste und kompakteste Tandem-Quadrupol-Massenspektrometer für den Tischeinsatz


Waters Corporation (NYSE:WAT) hat heute das neue System Xevo™ TQ Absolute vorgestellt, das empfindlichste und kompakteste Tandem-Massenspektrometer seiner Klasse für den Tischeinsatz.i


Diese

Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System, to Its Range of Scan-Free and Fingerprick†-Free Devices
Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System, to Its Range of Scan-Free and Fingerprick†-Free Devices


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the new Dexcom ONE Continuous Glucose Monitoring System will